BMS Praises England’s New HTA Process As Opdualag Gets Funding For Melanoma

England’s health technology assessment body, NICE, and the medicines regulator, the MHRA, are “leading the way” in making innovation available to patients and ensuring an efficient and proportionate use of resources, according to BMS.